Cencora, a pharmaceutical and biotechnology company based in Pennsylvania, is expanding in Dothan with an $80 million ...

California biotech company Cellipont has opened a new 76,000 square foot cell therapy headquarters in The Woodlands' booming ...

Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

New Wave Biotech has launched a new Life Cycle Assessment (LCA) tool tailored to the biotechnology sector, designed to ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...

Evaxion Biotech ( ($EVAX) ) has issued an update. On November 6, 2025, Evaxion A/S announced significant business developments and financial ...

October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

Life sciences companies have faced a turbulent 2025. Here's what Philadelphia's biotech leaders are saying about the state of ...

Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...